openPR Logo
Press release

SNP Genotyping and Analysis Market Intelligence and Analysis for Period 2013 - 2019

01-29-2018 06:57 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
SNP Genotyping and Analysis Market Intelligence and Analysis

The falling prices of sequencing have fanned research and development in SNP genotyping and analysis. Moreover, an increasing demand for breeding livestock will prove conducive to the growth of the global SNP genotyping and analysis market, says TMR in a new market research report. According to the report, titled, ‘SNP Genotyping and Analysis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,’ the market will exhibit strong growth over the next three years. The market, which approximated US$2.38 bn in 2012, is expected to grow in value to reach US$9.48 bn by 2019.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/snp-single-nucleotide-polymorphism-market.html

The introduction of new SNP genotyping technologies will have a far-reaching impact on the overall growth of the market, says TMR’s report. The positive impact of this trend will be visible in the robust growth projected to be exhibited by the market. The market is on course to exhibiting a compounded annual growth rate (CAGR) of 21.8% from 2013 to 2019. The heightened research interest in pharmacogenomics and livestock breeding has created opportunities of high economic value for companies in the SNP genotyping and analysis market.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=432

Many of these opportunities will also make it possible for the average consumer in both developed and developing economies to access genotyping. However, the dynamics of the market are affected by the fact that there are nearly eight to 10 different kinds of SNP genotyping techniques, including Microarray, aqMan, MALDI-TOF, and SNPlex. What also aids the market’s growth is that over two million SNP genotypes have been added to a global database as part of the Human Genome Project. That has spurred numerous R&D activities in the genotyping and analysis market. Companies have invested bullishly in understanding how new diagnostic techniques similar to companion diagnostics can be developed so as to understand genome behavior as individuals age.

Download Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=432

Food crops such as corn, oats, rice, wheat, and maize are undergoing intensive research after SNP genotyping in the agriculture sector having gained widespread acceptance. Several widely accepted products have been launched on the market as a result of this. A case in point is Affymetrix’s 44K array that is now extensively used for rice genotyping and helps farmers identify factors impacting yield.

The report segments the global genotyping market based on the following criteria: Technology, application, and geography. By technology, the market is segmented into Taqman Allelic Discrimination, SNP by Pyrosequencing, AB SNPlex, SNP GeneChips and Microarrays, MassARRAY MALDI-TOF. Likewise, by application type, the market is divided into the following segments: Breeding and animal livestock, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and diagnostic research.

Furthermore, on the basis of geography, the market has been segmented into: Europe, North America, Asia Pacific, and Rest of the World. Regionally, North America represents the largest market for SNP technologies. A strong demand from the pharmacogenomics and livestock breeding sectors is likely to positively impact the global genotyping and analysis market. However, the highest growth is expected to come from the Asia Pacific region, which has been projected to report a CAGR of 23.1% through the report’s forecast period.

Leading companies profiled in this report include Illumina Inc., Roche, Life Technologies Corporation, Sequenom, Affymetrix Inc, and Fluidigm.

Purchase this Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=432<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SNP Genotyping and Analysis Market Intelligence and Analysis for Period 2013 - 2019 here

News-ID: 919020 • Views:

More Releases from Transparency Market Research

Active Pharmaceutical Ingredients (API) Market Size Worth USD 466.9 Billion by 2035 | Growing at 5.8% CAGR - Analysis by TMR
Active Pharmaceutical Ingredients (API) Market Size Worth USD 466.9 Billion by 2 …
The global Active Pharmaceutical Ingredients (API) market is set for steady expansion over the next decade, driven by rising pharmaceutical production, increasing chronic disease prevalence, and advancements in biopharmaceutical manufacturing technologies. Valued at USD 250.9 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2025 to 2035, reaching USD 466.9 billion by the end of the forecast period. APIs - the
Brain-Computer Interface Market Size Worth USD 4.3 Billion by 2035 | Rising at 11.2% CAGR - Analysis by TMR
Brain-Computer Interface Market Size Worth USD 4.3 Billion by 2035 | Rising at 1 …
The global brain-computer interface (BCI) market is poised for robust expansion, driven by rapid advancements in neurotechnology, artificial intelligence (AI), and human-machine interaction. Valued at USD 1.3 billion in 2024, the market is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2025 to 2035, reaching an estimated USD 4.3 billion by the end of the forecast period. With neurotechnology gaining momentum in medical rehabilitation, gaming, defense,
Medical Education Market Size Worth USD 247.0 Billion by 2035 | Rising at 10.2% CAGR - Analysis by TMR
Medical Education Market Size Worth USD 247.0 Billion by 2035 | Rising at 10.2% …
The global medical education market is undergoing rapid transformation, driven by digitalization, rising healthcare workforce demand, and increased investment in online and simulation-based learning. Valued at USD 83.2 billion in 2024, the industry is projected to grow at a compound annual growth rate (CAGR) of 10.2% between 2025 and 2035, reaching USD 247.0 billion by the end of the forecast period. The evolution of medical education from traditional classroom-based training to
Home Healthcare Market Size Worth USD 1,006.4 Billion by 2035 | Rising at 10.3% CAGR - Analysis by TMR
Home Healthcare Market Size Worth USD 1,006.4 Billion by 2035 | Rising at 10.3% …
The global home healthcare market is on a strong growth trajectory, driven by technological innovation, aging populations, and the rising demand for personalized and convenient medical services. Valued at USD 343.0 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 10.3% between 2025 and 2035, reaching a value of USD 1,006.4 billion by the end of the forecast period. The transformation of healthcare

All 5 Releases


More Releases for SNP

SNP Genotyping Market to Reach USD 39.2 Bn by 2034
Introduction Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation, occurring once in every 300 nucleotides on average. SNP genotyping has become a cornerstone of genomics, enabling researchers and clinicians to identify genetic predispositions, understand disease mechanisms, develop targeted therapies, and improve crop and livestock breeding. The integration of high-throughput technologies, falling sequencing costs, and rising demand for personalized medicine are fueling market growth. By 2024, the SNP genotyping
Booming SNP Genotyping Market: Rapid Growth, Major Players, and Emerging Trends
"The global single nucleotide polymorphism genotyping market showcases a robust growth rate powered by advancements and increasing demand in the field. What Is The Projected Market Size Of The Global Single Nucleotide Polymorphism (SNP) Genotyping Market And Its Growth Rate? The SNP genotyping market size has experienced rapid growth in recent years and is projected to continue this trend. Differences in data are as follows: • Growth from $10.3 billion in 2024 to
SNP Chips: Revolutionizing Genetic Research and Breeding in the Modern Era
In the rapidly evolving landscape of genomics, Single Nucleotide Polymorphism (SNP) chips have emerged as powerful tools transforming genetic research and breeding practices across diverse sectors, from agriculture to livestock and even human health. As technological advancements continue to accelerate, these chips are becoming increasingly sophisticated, allowing scientists to unravel the complexities of the genome with unprecedented precision and efficiency. The Rise of SNP Chips SNP chips, also known as genotyping arrays,
SNP genotyping Market 2023 Driving Factors Forecast Research 2029
SNP genotyping market is anticipated to grow at a significant CAGR of 20.5% during the forecast period. The market is mainly driven by increasing R&D projects in genotyping domain, and rising funding in the biotechnology industry. The biopharmaceutical companies are investing heavily in the R&D projects, attributed to advances and discoveries. From genomics to personalized medicines, all the recent advancement has created significant scope in developing unique treatment options for
SNP genotyping Market Outlook 2029: Presents Market Insights & Depth Analysis
The global SNP Genotyping market is anticipated to grow at a CAGR of 20.5% during the forecast period (2023-2030). Genotyping detects tiny differences in genetic sequence within populations such as single-nucleotide polymorphisms (SNPs). SNP technology is used to study the genetic elements of complex diseases. SNPs are markers that are utilized in different human ailments and are employed in pharmacogenomics to provide medicine according to the need. Thus, the rising
Explore Single Nucleotide Polymorphism (SNP) Genotyping Market Demand 2020 - 202 …
According to a new report published by Allied Market Research, titled, "World Single Nucleotide Polymorphism (SNP) Genotyping Market - Opportunities and Forecasts, 2019-2026" The global market size of Single Nucleotide Polymorphism (SNP) Genotyping is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2020 to 2027. Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1464?utm_source=openpr&utm_medium=Niranjan Key